JMPWA
ATYR

JP Morgan Private Wealth Advisors’s aTyr Pharma ATYR Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,579
Closed -$100K – 1629
2020
Q2 		$100K Hold
22,579
– – ﹤0.01% 1514
2020
Q1 		$63K Hold
22,579
– – ﹤0.01% 1384
2019
Q4 		$94K Buy
+22,579
New +$87.2K ﹤0.01% 1441

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ATYR Position: Q3 2020 in Review

JP Morgan Private Wealth Advisors sold out of aTyr Pharma (ATYR) in Q3 2020, closing a stake of 22,579 shares — an estimated $100K sold.

JP Morgan Private Wealth Advisors first reported a position in ATYR in Q4 2019 and held it in 3 quarters. The position peaked at $100K in Q2 2020. 25 funds tracked by Wall St. Rank hold ATYR as of Q3 2020.

  • JP Morgan Private Wealth Advisors reported no remaining aTyr Pharma position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 22,579 aTyr Pharma shares in Q3 2020, an estimated $100K.
  • JP Morgan Private Wealth Advisors first reported a position in aTyr Pharma in Q4 2019 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's aTyr Pharma position peaked at $100K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.